Search Results - "Esperou, H."

Prospective validation of a novel IV busulfan fixed dosing for paediatric patients to improve therapeutic AUC targeting without drug monitoring by Vassal, G., Michel, G., Espérou, H., Gentet, J. C., Valteau-Couanet, D., Doz, F., Mechinaud, F., Galambrun, C., Neven, B., Zouabi, H., Nguyen, L., Puozzo, C.

“…Introduction Oral busulfan clearance is age-dependent and children experience a wide variability in plasma exposure. BSA- or age-based dosing is used with…”
Get full text

Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation by BERGERON, A, BELLE, A, CHEVRET, S, RIBAUD, P, DEVERGIE, A, ESPEROU, H, ADES, L, GLUCKMAN, E, SOCIE, G, TAZI, A

“…Bronchiolitis obliterans (BO) is a potentially life-threatening complication following allogeneic stem cell transplantation (SCT) and usually carries a poor…”
Get full text

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies by FERRY, C, GEMAYELL, G, GLUCKMAN, E, BARUCHEL, A, SOCIE, G, ROCHA, V, LABOPIN, M, ESPEROU, H, ROBIN, M, DE LATOUR, R. P, RIBAUD, P, DEVERGIE, A, LEBLANC, T

“…We analyzed long-term outcomes and psycho-social aspects in 112 children with malignancies surviving 1 year after hematopoietic stem cell transplantation. At…”
Get full text

Bone markers after total body irradiation in childhood by Couto-Silva, A-C, Trivin, C, Espérou, H, Michon, J, Baruchel, A, Souberbielle, J-C, Brauner, R

“…Total body irradiation (TBI) can cause short stature because of decreased growth hormone (GH) and skeletal abnormalities. To evaluate the plasma concentrations…”
Get full text

Ovarian function after bone marrow transplantation during childhood by THIBAUD, E, RODRIGUEZ-MACIAS, K, TRIVIN, C, ESPEROU, H, MICHON, J, BRAUNER, R

“…Ovarian failure is often brought about by the conditioning protocol used for bone marrow transplantation (BMT). We monitored ovarian function in 31 girls…”
Get full text

Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients by PEFFAULT DE LATOUR, R, ASSELAH, T, MARCELLIN, P, SOCIE, G, LEVY, V, SCIEUX, C, DEVERGIE, A, RIBAUD, P, ESPEROU, H, TRAINEAU, R, GLUCKMAN, E, VALLA, D

“…We recently reported an increased incidence of cirrhosis in hepatitis C virus (HCV)-infected stem cell transplant (SCT) recipients. Here, we describe our…”
Get full text

Final height and gonad function after total body irradiation during childhood by COUTO-SILVA, A.-C, TRIVIN, C, ESPEROU, H, MICHON, J, BARUCHEL, A, LEMAIRE, P, BRAUNER, R

“…Short stature and gonad failure can be a side effect of total body irradiation (TBI). The purpose of the study was to evaluate the factors influencing final…”
Get full text

Resistant Herpes Simplex Virus Type 1 Infection: An Emerging Concern after Allogeneic Stem Cell Transplantation by Chen, Yolande, Scieux, Catherine, Garrait, Valérie, Socié, Gérard, Rocha, Vanderson, Molina, Jean-Michel, Thouvenot, Danielle, Morfin, Florence, Hocqueloux, Laurent, Garderet, Laurent, Espérou, Hélène, Sélimi, Fadhéla, Devergie, Agnès, Leleu, Ghislaine, Aymard, Michèle, Morinet, Frédéric, Gluckman, Eliane, Ribaud, Patricia

“…Fourteen cases of severe acyclovir-resistant herpes simplex virus type 1 (HSV-1) infection, 7 of which showed resistance to foscarnet, were diagnosed among 196…”
Get full text

A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors by ROBIN, M, GUARDIOLA, P, DEVERGIE, A, YESHURUN, M, SHAPIRO, S, ESPEROU, H, RIBAUD, P, ROCHA, V, GLUCKMAN, E, SOCIE, G

“…We report long-term outcome in 102 patients with cCML transplanted from an HLA-identical sibling donor from 1982 to 1998. The conditioning regimen was based on…”
Get full text

Factors affecting gonadal function after bone marrow transplantation during childhood by COUTO-SILVA, A. C, TRIVIN, C, THIBAUD, E, ESPEROU, H, MICHON, J, BRAUNER, R

“…Conditioning for bone marrow transplantation (BMT) may alter viability of germ cells and production of gonadal hormones. We analyzed the risk factors for…”
Get full text

Survival and Prognostic Factors of Invasive Aspergillosis After Allogeneic Bone Marrow Transplantation by Ribaud, Patricia, Chastang, Claude, Latgé, Jean-Paul, Baffroy-Lafitte, Laurence, Natquet, Nathalie, Devergie, Agnès, Espérou, Hélène, Sélimi, Fadhéla, Rocha, Vanderson, Derouin, Francis, Socié, Gérard, Gluckman, Eliane

“…To determine prognostic factors for survival in bone marrow transplant recipients with invasive aspergillosis (IA), we retrospectively reviewed 27 IA cases…”
Get full text

DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation by LOISEAU, P, ESPEROU, H, GLUCKMAN, E, CHARRON, D, BUSSON, M, SGHIRI, R, TAMOUZA, R, HILARIUS, M, RAFFOUX, C, DEVERGIE, A, RIBAUD, P, SOCIE, G

“…In order to evaluate the impact of HLA-DBP1 incompatibilities on the occurrence of acute graft-versus-host disease (GVHD) in unrelated hematopoietic cell…”
Get full text

Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire by Mohty, M, Labopin, M, Balère, M L, Socié, G, Milpied, N, Tabrizi, R, Ifrah, N, Hicheri, Y, Dhedin, N, Michallet, M, Buzyn, A, Cahn, J-Y, Bourhis, J-H, Blaise, D, Raffoux, C, Espérou, H, Yakoub-Agha, I

“…This retrospective report assessed the impact of rabbit antithymocyte globulins (ATG), incorporated within a standard myeloablative conditioning regimen prior…”
Get full text

Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term responders by BITTENCOURT, H, ROCHA, V, SOCIE, G, GLUCKMAN, E, FILION, A, IONESCU, I, HERR, A.-L, GAMIER, F, ADES, L, ESPEROU, H, DEVERGIE, A, RIBAUD, P

“…Poor graft function (PGF) is a frequent cause of morbidity after allogeneic hematopoietic stem cell transplantation (allo-HSCT). To study the value of…”
Get full text

Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia by CORDONNIER, C, MAURY, S, GLÜCKMAN, E, KUENTZ, M, DURAND-ZALESKI, I, ESPEROU, H, PAUTAS, C, BEAUNE, J, RODET, M, LAGRANGE, J.-L, ROUARD, H, BEAUMONT, J.-L, BASSOMPIERRE, F

“…Allogeneic hematopoietic stem cell transplantation (SCT) is a widely used, cost-intensive procedure. Although pretransplant nonmyeloablative (NMA) or…”
Get full text

Hypersensitivity pneumonitis related to imatinib mesylate by Bergeron, A, Bergot, E, Vilela, G, Ades, L, Devergie, A, Espérou, H, Socié, G, Calvo, F, Gluckman, E, Ribaud, P, Rousselot, Ph, Tazi, A

Get full text

Unusual complications after bone marrow transplantation for dyskeratosis congenita by Rocha, Vanderson, Devergie, Gnès, SociÉ, Gerard, Ribaud, Patricia, EspÉrou, Hélène, Parquet, Nathalie, Gluckman, Eliane

“…Dyskeratosis congenita (DC) is a rare inherited disorder often associated with aplastic anaemia. We report the cases of five boys transplanted with an…”
Get full text

New oral formulation of cyclosporin A (Neoral) pharmacokinetics in allogeneic bone marrow transplant recipients by PARQUET, N, REIGNEAU, O, HUMBERT, H, GUIGNARD, M, RIBAUD, P, SOCIE, G, DEVERGIE, A, ESPEROU, H, GLUCKMAN, E

“…Cyclosporin A (CsA) absorption is variable in bone marrow transplant (BMT) patients compromising the efficacy of graft-versus-host disease prevention. Neoral,…”
Get full text

Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) by MILLOT, F, ESPEROU, H, PLOUVIER, E, ROME, A, GUILHOT, J, GUILHOT, F, BORDIGONI, P, DALLE, J-H, MICHALLET, M, MICHEL, G, BOURHIS, J. L, KUENZ, M, BLAISE, D, GARBAN, F

“…To determine the results of allogeneic hematopoietic stem cell (HSC) transplantation for chronic myelogenous leukemia (CML) at various stages of the disease in…”
Get full text

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database by DHEDIN, N, GIRAUDIER, S, LAPORTE, J. L, GUILHOT, F, KUENTZ, M, GAULARD, P, ESPEROU, H, IFRAH, N, MICHALLET, M, MILPIED, N, RIO, B, CAHN, J. Y, MOLINA, L

“…The place of allogeneic bone marrow transplantation (BMT) in the treatment of aggressive non‐Hodgkin's lymphoma (NHL) remains controversial. We conducted a…”
Get full text